Cargando...

Antimalarial Effects of Human Immunodeficiency Virus Type 1 Protease Inhibitors Differ from Those of the Aspartic Protease Inhibitor Pepstatin

Human immunodeficiency virus type 1 protease inhibitors (HIVPIs) and pepstatin are aspartic protease inhibitors with antimalarial activity. In contrast to pepstatin, HIVPIs were not synergistic with a cysteine protease inhibitor or more active against parasites with the cysteine protease falcipain-2...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Parikh, Sunil, Liu, Jun, Sijwali, Puran, Gut, Jiri, Goldberg, Daniel E., Rosenthal, Philip J.
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology 2006
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC1479139/
https://ncbi.nlm.nih.gov/pubmed/16723585
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00022-06
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!